Table 2.
Baseline Characteristics (n = 153)
| Sex (male) | 80 (52.3) |
|---|---|
| Age | 67 ± 13 |
| Medical History | |
| HT | 91 (59.5) |
| DM | 29 (19) |
| COPD | 9 (5.9) |
| iCVA | 12 (7.8) |
| TIA | 16 (10.5) |
| CAD | 10 (6.5) |
| Heart failure | 2 (1.3) |
| Valvular disease | 10 (6.5) |
| Bradytachy syndrome | 1 (0.7) |
| Other arrhythmia | 1 (0.7) |
| Medication | |
| Ca antagonist | 24 (15.7) |
| Beta‐blocker | 36 (23.5) |
| Class 1 AAD | 1 (0.7) |
| Sotalol | 0 (0) |
| Amiodarone | 0 (0) |
| Antiplatelet | 132 (86.3) |
| OAC | 5 (3.3) |
| Statine | 117 (76.5) |
| ACE inhibitor | 42 (27.5) |
| AT2 inhibitor | 25 (16.3) |
| Diuretics | 27 (17.6) |
Data are presented as mean (SD) or number (%). HT = hypertension; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease; iCVA = ischemic cerebrovascular accident; TIA = transient ischemic attack; CAD = coronary artery disease; AFl = atrial flutter; AAD = antiarrhythmic drugs; OAC = oral anticoagulant; ACE = angiotensin converting enzyme; AT2 = angiotensin II inhibitor.